Opendata, web and dolomites

PRECODE SIGNED

PancREatic Cancer OrganoiDs rEsearch Network

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PRECODE project word cloud

Explore the words cloud of the PRECODE project. It provides you a very rough idea of what is the project "PRECODE" about.

investigation    innovation    animal    metabolomics    establishing    sweden    cutting    career    consists    international    function    union    perfect    doctorate    pancreatic    professional    deduct    goes    beneficiaries    firmly    connect    intersectorial    cultivate    techniques    medicine    precode    variety    training    generation    3r    thereof    disease    mission    small    patient    molecular    tool    reduce    italy    esrs    train    therapy    education    excellence    micro    time    drugs    fulfils    sequencing    precision    groups    capacitation    central    viewed    technologies    creative    vitro    edge    workshops    organoid    competences    biology    cancer    shared    advocate    clinical    organs    group    material    isolated    minimal    fit    earn    goals    recapitulate    learning    glove    experiments    network    interdisciplinary    secondments    organoids    combination    throughput    drug    innovative    manipulate    terrible    germany    15    sources    organization   

Project "PRECODE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITATSKLINIKUM ERLANGEN 

Organization address
address: MAXIMILIANSPLATZ 2
city: ERLANGEN
postcode: 91054
website: www.uk-erlangen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 3˙992˙891 €
 EC max contribution 3˙992˙891 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2023-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITATSKLINIKUM ERLANGEN DE (ERLANGEN) coordinator 252˙788.00
2    ASTRAZENECA UK LIMITED UK (CAMBRIDGE) participant 303˙172.00
3    UNIVERSITY OF GLASGOW UK (GLASGOW) participant 303˙172.00
4    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 281˙982.00
5    UMEA UNIVERSITET SE (UMEA) participant 281˙982.00
6    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN IE (DUBLIN) participant 274˙684.00
7    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 265˙619.00
8    MIMETAS BV NL (Leiden) participant 265˙619.00
9    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 265˙619.00
10    UNIVERSITA DEGLI STUDI DI VERONA IT (VERONA) participant 261˙499.00
11    CELLPHENOMICS GMBH DE (BERLIN) participant 252˙788.00
12    FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG DE (ERLANGEN) participant 252˙788.00
13    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) participant 252˙788.00
14    UNIVERSIDAD DE NAVARRA ES (PAMPLONA) participant 250˙904.00
15    GDANSKI UNIWERSYTET MEDYCZNY PL (GDANSK) participant 227˙478.00

Map

 Project objective

The PRECODE Network (PancREatic Cancer OrganoiDs rEsearch) central mission is to establish pancreatic organoid research firmly in the European Union, by training the next generation of creative and innovative researchers in pancreatic cancer. This will be done through a shared doctorate program of excellence that fulfils the three “I”: international, interdisciplinary and intersectorial. Organoids can be viewed as small micro-organs which can recapitulate the organization and the function thereof. As micro-organs organoids can be used to reduce animal experiments and help to reach 3R goals. Organoids from pancreatic cancer will help us to learn which drugs might help in the therapy of this terrible disease. They can be isolated from a variety of clinical sources with minimal material needed. This makes them a perfect tool for precision medicine. Sequencing, metabolomics and high throughput in vitro experiments to deduct the best possible drug combination fit hand in glove with this approach. Training of ESRs will be achieved by e-learning, workshops and secondments. They will earn to cultivate and manipulate organoids as well as cutting edge molecular biology techniques. Therefore our work group consists of 15 beneficiaries and 7 partner organization (including three patient advocate groups from Sweden, Italy and Germany) to develop those technologies and to train ESRs in their application. PRECODE will therefore connect the concepts of investigation, education and innovation establishing a capacitation for the ESRs that goes beyond the state of the art and that will allow them to improve their competences and their professional career at the same time that we advance towards innovation in the field of pancreatic cancer research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRECODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PRECODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

Shape-IT (2019)

Supporting the interaction of Humans and Automated vehicles: Preparing for the EnvIronment of Tomorrow

Read More  

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

DISTINCT (2019)

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

Read More